Asia Pacific Human Leukocyte Antigen (HLA) Testing Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis By Product and service (Reagents & Consumables, Instruments, and Software & Services), Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), and End User (Independent Reference Laboratories, Hospitals and Transplant Centers, and Others)

No. of Pages: 164
Report Code: BMIRE00025758
Category: Life Sciences
Asia Pacific Human Leukocyte Antigen (HLA) Testing Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Regional Analysis

6.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue 2020-2028 (US$ Million)
6.3 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Forecast Analysis

7. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Analysis – by Product and service

7.1 Reagents & Consumables
  • 7.1.1 Overview
  • 7.1.2 Reagents & Consumables: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Instruments
  • 7.2.1 Overview
  • 7.2.2 Instruments: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Software & Services
  • 7.3.1 Overview
  • 7.3.2 Software & Services: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Analysis – by Technology

8.1 Molecular Assay Technologies
  • 8.1.1 Overview
  • 8.1.2 Molecular Assay Technologies: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Non-Molecular Assay Technologies
  • 8.2.1 Overview
  • 8.2.2 Non-Molecular Assay Technologies: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Analysis – by End User

9.1 Independent Reference Laboratories
  • 9.1.1 Overview
  • 9.1.2 Independent Reference Laboratories: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Hospitals and Transplant Centers
  • 9.2.1 Overview
  • 9.2.2 Hospitals and Transplant Centers: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific
  • 10.2.1 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.2.1.1 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
    • 10.2.1.1.2 China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
    • 10.2.1.1.3 China: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User
  • 10.2.1.2 India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
    • 10.2.1.2.2 India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
    • 10.2.1.2.3 India: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User
  • 10.2.1.3 Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
    • 10.2.1.3.2 Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
    • 10.2.1.3.3 Japan: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User
  • 10.2.1.4 Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
    • 10.2.1.4.2 Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
    • 10.2.1.4.3 Australia: Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User
  • 10.2.1.5 Rest of Asia-Pacific : Asia Pacific Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
    • 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
    • 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 CareDx
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 QIAGEN
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Illumina, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Bio-Rad Laboratories, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 TBG Diagnostics Limited
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 F. HOFFMANN-LA ROCHE LTD.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Takara Bio Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Luminex Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Asia Pacific Human Leukocyte Antigen (HLA) Testing Market

  • THERMO FISHER SCIENTIFIC INC.
  • CareDx
  • QIAGEN
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • TBG Diagnostics Limited
  • F. HOFFMANN-LA ROCHE LTD.
  • Takara Bio Inc.
  • Luminex Corporation
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)